Latigo Bio's IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs
Latigo Bio's IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs
Latigo Biotherapeutics
Latigo Biotherapeutics is a biopharmaceutical company.
Latigo Biotherapeutics is a biopharmaceutical company.
Latigo Bio's IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs